COO (The Cooper) OCF Margin %: 16.90% (As of Apr. 2026) — 27% Below Median


COO The Cooper Companies Inc COO
85 GF Score
Price $68.86
GF Value $100.85
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper OCF Margin %?

The Cooper COO +4.04% 85 OCF Margin % is 16.90% as of Apr. 2026, which is 27% below its 10-year median of 23.10. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.85 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, The Cooper ranks better than 85.03% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. The Cooper's Cash Flow from Operations for the three months ended in Apr. 2026 was $183 Mil. The Cooper's Revenue for the three months ended in Apr. 2026 was $1,082 Mil. Therefore, The Cooper's OCF Margin % for the quarter that ended in Apr. 2026 was 16.90%.

As of today, The Cooper's current OCF Yield % is 7.10%.

The historical rank and industry rank for The Cooper's OCF Margin % or its related term are showing as below:

COO' s OCF Margin % Range Over the Past 10 Years
Min: 16.91   Med: 23.1   Max: 27.75
Current: 22.52


During the past 13 years, the highest OCF Margin % of The Cooper was 27.75%. The lowest was 16.91%. And the median was 23.10%.

COO's OCF Margin % is ranked better than
85.03% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs COO: 22.52


The Cooper OCF Margin % Related Terms


The Cooper OCF Margin % Historical Data

* Premium members only.

The historical data trend for The Cooper's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper OCF Margin % Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.27 20.93 16.91 18.21 19.45

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.60 24.65 23.27 25.48 16.90

COO vs ALGN, SOLV, BAX: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, The Cooper's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's OCF Margin % distribution charts can be found below:

* The bar in red indicates where The Cooper's OCF Margin % falls into.


COO
85GF Score
The Cooper Companies Inc COO
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

The Cooper's OCF Margin for the fiscal year that ended in Oct. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=796.1/4092.4
=19.45 %

The Cooper's OCF Margin for the quarter that ended in Apr. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=182.8/1081.5
=16.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 16.90% mean?
The Cooper (COO) has a OCF Margin % of 16.90% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on The Cooper and its competitors. This is 27% below median its historical median of 23.10. Over the past decade, The Cooper's OCF Margin % has ranged from 16.91 to 27.75. According to the industry distribution chart, The Cooper ranks #122 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 15%.
Is The Cooper's OCF Margin % too high?
The Cooper's current OCF Margin % of 16.90% is 27% below median its 10-year median of 23.10. Over the past 10 years, this metric has ranged from a low of 16.91 to a high of 27.75. The Medical Devices & Instruments industry median OCF Margin % is 5.86. The Cooper's value of 16.90% is 188.4% above this industry median. Based on the distribution chart, The Cooper ranks #122 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's OCF Margin % compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #122 out of 815 companies for OCF Margin %. This places The Cooper in the top 15% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. The Cooper's value of 16.90% is 188.4% above this benchmark. Historically, The Cooper's own OCF Margin % has ranged from 16.91 to 27.75 over the past decade. While the company's 10-year median is 23.10 vs. the industry median of 5.86, The Cooper has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current OCF Margin % of 16.90% is 188.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current OCF Margin % is 16.90%, which is 27% below median its own 10-year median of 23.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.85, compared to a current price of $68.86 — trading 31.7% below its estimated fair value. The current OCF Margin % is 16.90%, which is 27% below median its 10-year median of 23.10 and 188.4% above the Medical Devices & Instruments industry median of 5.86. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For The Cooper (COO), the current OCF Margin % is 16.90% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of $68.86 is trading 31.7% below its estimated GF Value™ of $100.85. GuruFocus considers The Cooper to be Significantly Undervalued.

Key valuation signals for COO:

  • OCF Margin %: 16.90% (27% below median its 10-year median of 23.10)
  • GF Value™: $100.85 vs. price of $68.86 (31.7% below fair value)
  • GF Score™: 85/100 with 3 warning signs
  • Industry Position: 188.4% above the Medical Devices & Instruments median (#122 of 815)

No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score

Get the complete analysis for COO

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.86
Price
$100.85
GF Value